Use of systemic medication in patients with oral lichen planus-a possible association with hypothyroidism

Oral Diseases

Volumn 19, Issue 3, 2013, Pages 313-319

  Robledo Sierra, J ^a   Mattsson, U ^a   Jontell, M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Comorbidity; Hypothyroidism; Levothyroxine; Mucosal diseases; Oral lichen planus

Indexed keywords

LEVOTHYROXINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; ALLERGY; ARTICLE; BEE STING; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOOD ALLERGY; GENDER; GRASS POLLEN; HUMAN; HYPOTHYROIDISM; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLLEN ALLERGY; PRIORITY JOURNAL; SMOKING; SYSTEMIC DISEASE; ADOLESCENT; ADVERSE DRUG REACTION; AGED; CHEMICALLY INDUCED; COMPLICATION; LICHEN PLANUS, ORAL; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; HYPOTHYROIDISM; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84884354201     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12009     Document Type: Article

References (46)

1. Aghini-Lombardi F, Antonangeli L, Martino E et al (1999). The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84: 561-566.
2. Al-Hashimi I, Schifter M, Lockhart PB et al (2007). Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (Suppl): S25e1-S25e12.
3. Ali AA, Suresh CS (2007). Oral lichen planus in relation to transaminase levels and hepatitis C virus. J Oral Pathol Med 36: 604-608.
4. Bagan JV, Thongprasom K, Scully C (2004). Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. Oral Dis 10: 401-403.
5. Bjoro T, Holmen J, Kruger O et al (2000). Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 143: 639-647.
6. Calissendorff J, Ljung R (2011). Thyroxin substitution and openangle glaucoma: a nationwide register-based study on filled prescriptions. Br J Ophthalmol 95: 592-594.
7. Carbone M, Arduino PG, Carrozzo M et al (2009). Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis 15: 235-243.
8. Carrozzo M, Gandolfo S, Carbone M et al (1996). Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25: 527-533.
9. Chang JY, Chiang CP, Hsiao CK, Sun A (2009). Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus. J Oral Pathol Med 38: 48-54.
10. Clayton R, Chaudhry S, Ali I, Cooper S, Hodgson T, Wojnarowska F (2010). Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition? Clin Exp Dermatol 35: 384-387.
11. Colvard MD, Nadimi H, Gargiulo AV (1986). Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva, case report Periodontal Case Rep 8: 69-70.
12. Compilato D, Paderni C, Di Fede O, Gulotta G, Campisi G (2011). Association of oral lichen planus with thyroid disease in a Finnish population: a retrospective case-control study: 'A different finding from a Mediterranean area'. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111: 12-13; author reply 13-4.
13. Dinsdale RC, Ormerod TP, Walker AE (1968). Lichenoid eruption due to chlorpropamide. Br Med J 1: 100.
14. Dreiher J, Shapiro J, Cohen AD (2009). Lichen planus and dyslipidaemia: a case-control study. Br J Dermatol 161: 626-629.
15. Erdogan M, Erdem N, Cetinkalp S et al (2009). Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine 36: 486-490.
16. Farhi D, Dupin N (2010). Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28: 100-108.
17. Ferguson MM, Wiesenfeld D, MacDonald DG (1984). Oral mucosal lichenoid eruption due to fenclofenac. J Oral Med 39: 39-40.
18. Ficarra G, Flaitz CM, Gaglioti D et al (1993). White lichenoid lesions of the buccal mucosa in patients with HIV infection. Oral Surg Oral Med Oral Pathol 76: 460-466.
19. Hamburger J, Potts AJ (1983). Non-steroidal anti-inflammatory drugs and oral lichenoid reactions. Br Med J (Clin Res Ed) 287: 1258.
20. Hay KD, Reade PC (1978). Methyldopa as a cause of oral mucous membrane reactions. Br Dent J 145: 195-203.
21. Hirota SK, Moreno RA, dos Santos CH, Seo J, Migliari DA (2011). Analysis of a possible association between oral lichen planus and drug intake. A controlled study. Med Oral Patol Oral Cir Bucal 16: e750-e756.
22. Jontell M, Mattsson U, Torgersson O (2005). MedView: an instrument for clinical research and education in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 55-63.
23. Kragelund C, Thomsen CE, Bardow A et al (2003). Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes. Oral Dis 9: 177-187.
24. Kragelund C, Hansen C, Reibel J et al (2009). Polymorphic drug metabolizing CYP-enzymes-a pathogenic factor in oral lichen planus? J Oral Pathol Med 38: 63-71.
25. Kragelund C, Hansen C, Reibel J et al (2010). Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions? J Oral Pathol Med 39: 497-505.
26. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH (1978). Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46: 518-539.
27. Läkemedelsindustriföreningen (2012). FASS ATC-register. Available at: http://www.fass.se/LIF/produktfakta/sok_lakemedel.jsp?expanded [accessed on 5 March 2012].
28. Lamey PJ, Gibson J, Barclay SC, Miller S (1990). Grinspan's syndrome: a drug-induced phenomenon? Oral Surg Oral Med Oral Pathol 70: 184-185.
29. Lin HP, Wang YP, Chia JS, Sun A (2011). Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus. J Formos Med Assoc 110: 169-174
30. Lodi G, Giuliani M, Majorana A et al (2004) Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 151: 1172-1181.
31. Markitziu A, Katz J, Pisanty S (1986). Lichenoid lesions of oral mucosa associated with ketoconazole. Mykosen 29: 317-322.
32. McCartan BE, McCreary CE, Healy CM (2003). Studies of drug-induced lichenoid reactions: criteria for case selection. Oral Dis 9: 163-164.
33. Paulusova V, Rosch C, Drizhal I et al (2010). Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus. Acta Odontol Scand 68: 193-198.
34. Potts AJ, Hamburger J, Scully C (1987). The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 64: 541-543.
35. Powell FC, Rogers RS III, Dickson ER (1983). Primary biliary cirrhosis and lichen planus. J Am Acad Dermatol 9: 540-545.
36. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010). Pathogenesis of oral lichen planus - a review. J Oral Pathol Med 39: 729-734.
37. Siponen M, Huuskonen L, Laara E, Salo T (2010). Association of oral lichen planus with thyroid disease in a Finnish population: a retrospective case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110: 319-324.
38. Sugerman PB, Satterwhite K, Bigby M (2000). Autocytotoxic Tcell clones in lichen planus. Br J Dermatol 142: 449-456.
39. Virta LJ, Eskelinen SI (2011). Prevalence of hypothyroidism in Finland - a nationwide prescription study. Eur J Clin Pharmacol 67: 73-77.
40. van der Waal I (2009). Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 14: E310-E314.
41. Weetman AP (2011). Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxf) 74: 411-418.
42. West AJ, Berger TG, LeBoit PE (1990). A comparative histopathologic study of photodistributed and nonphotodistributed lichenoid drug eruptions. J Am Acad Dermatol 23: 689-693.
43. WHO Collaborating Centre for Drug Statistics Methodology (2011a). ATC/DDD index 2012. Available at: http://www.whocc.no/atc_ddd_index/ [accessed on 5 March 2012].
44. WHO Collaborating Centre for Drug Statistics Methodology (2011b). Guidelines for ATC classification and DDD assignment 2012. Available at: http://www.whocc.no/atc_ddd_publications/guidelines/[accessed on 5 March 2012].
45. Wilson DJ (1946). Eczematous and pigmentary lichenoid dermatitis; atypical lichen planus; preliminary report. Arch Derm Syphilol 54: 377-396.
46. World Health Organization (2010). International statistical classification of diseases and related health problems 10th revision. Available at: http://apps.who.int/classifications/icd10/browse/2010/en [accessed on 5 March 2012].